223 related articles for article (PubMed ID: 11484897)
1. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography.
Schirrmeister H; Buck A; Guhlmann A; Reske SN
Thyroid; 2001 Jul; 11(7):677-83. PubMed ID: 11484897
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
3. F-18 Sodium Fluoride Positron Emission Tomography/Computed Tomography for Detection of Thyroid Cancer Bone Metastasis Compared with Bone Scintigraphy.
Lee H; Lee WW; Park SY; Kim SE
Korean J Radiol; 2016; 17(2):281-8. PubMed ID: 26957915
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
[TBL] [Abstract][Full Text] [Related]
5. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.
Krüger S; Buck AK; Mottaghy FM; Hasenkamp E; Pauls S; Schumann C; Wibmer T; Merk T; Hombach V; Reske SN
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1807-12. PubMed ID: 19504092
[TBL] [Abstract][Full Text] [Related]
6. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.
Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H
J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356
[TBL] [Abstract][Full Text] [Related]
7. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
Schirrmeister H; Guhlmann A; Elsner K; Kotzerke J; Glatting G; Rentschler M; Neumaier B; Träger H; Nüssle K; Reske SN
J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
[TBL] [Abstract][Full Text] [Related]
10. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T
Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.
Schirrmeister H; Glatting G; Hetzel J; Nüssle K; Arslandemir C; Buck AK; Dziuk K; Gabelmann A; Reske SN; Hetzel M
J Nucl Med; 2001 Dec; 42(12):1800-4. PubMed ID: 11752076
[TBL] [Abstract][Full Text] [Related]
12. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879
[TBL] [Abstract][Full Text] [Related]
13. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography.
Schirrmeister H; Guhlmann A; Kotzerke J; Santjohanser C; Kühn T; Kreienberg R; Messer P; Nüssle K; Elsner K; Glatting G; Träger H; Neumaier B; Diederichs C; Reske SN
J Clin Oncol; 1999 Aug; 17(8):2381-9. PubMed ID: 10561300
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of (18)F-Fluoride positron emission tomography for assessment of metastatic bone tumor.
Tateishi U; Morita S; Taguri M; Shizukuishi K; Minamimoto R; Kawaguchi M; Murano T; Terauchi T; Inoue T; Kim EE
Ann Nucl Med; 2010 Aug; 24(7):523-31. PubMed ID: 20559896
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of bone scintigraphy and (18)F-FDG PET/CT in bone metastases of lung cancer patients].
Portilla-Quattrociocchi H; Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; de Arcocha Torres M; Medina-Quiroz P; del Castillo R; Rubio-Vassallo A; Carril JM
Rev Esp Med Nucl; 2011; 30(1):2-7. PubMed ID: 21208693
[TBL] [Abstract][Full Text] [Related]
16.
Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
[TBL] [Abstract][Full Text] [Related]
17. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
[TBL] [Abstract][Full Text] [Related]
18. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
Chua S; Gnanasegaran G; Cook GJ
Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
[TBL] [Abstract][Full Text] [Related]
19. ¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.
Withofs N; Grayet B; Tancredi T; Rorive A; Mella C; Giacomelli F; Mievis F; Aerts J; Waltregny D; Jerusalem G; Hustinx R
Nucl Med Commun; 2011 Mar; 32(3):168-76. PubMed ID: 21076343
[TBL] [Abstract][Full Text] [Related]
20. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]